Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Linda Härmark"'
Autor:
Francesco Schievano, Kissa W. Mwamwitwa, Seth Kisenge, Elice Mmari, Alemayehu Duga, Siphesihle Nhlabatsi, Cassandra Elagbaje, Abiodun Sadikat Abiola, Solomon Getnet Meshesha, Silvia Pagani, Riccardo Lora, Alberto Sabaini, Frank Cobelens, Linda Härmark, Eric Battey Eko, Anita Conforti, Mauro Venegoni, Lara Magro, Ugo Moretti
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionEfforts to improve medication access in low-and middle-income countries, particularly in Sub-Saharan Africa, have made progress, especially in the fight against infectious diseases such as tuberculosis. However, challenges exist in establ
Externí odkaz:
https://doaj.org/article/2f90c022a6d946dca96ecd23aef3259b
Autor:
Alemayehu L. Duga, Sibongile Magongo, Siphesihle Nhlabatsi, Denis O. Ladwar, Linda Härmark, Leàn Rolfes
Publikováno v:
AIDS Research and Therapy, Vol 19, Iss 1, Pp 1-5 (2022)
Abstract Background Dolutegravir (DTG) is an Integrase Strand Transfer Inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV infection. It is available in a number of pharmaceutical preparations includin
Externí odkaz:
https://doaj.org/article/5cb433d74cd64154b72ab7ca4d9b0a29
Autor:
Thomas Lieber, Helen R. Gosselt, Pelle C. Kools, Okko C. Kruijssen, Stijn N. C. Van Lierop, Linda Härmark, Florence P. A. M. Van Hunsel
Publikováno v:
Frontiers in Drug Safety and Regulation, Vol 3 (2023)
Objective: To improve a previously developed prediction model that could assist in the triage of individual case safety reports using the addition of features designed from free text fields using natural language processing.Methods: Structured featur
Externí odkaz:
https://doaj.org/article/428dac1dba2b42fabada53a1599d3902
Autor:
Everdina W. Tiemersma, Ibrahim Ali, Asnakech Alemu, Yohanna Kambai Avong, Alemayehu Duga, Cassandra Elagbaje, Ambrose Isah, Alexander Kay, Blandina Theophil Mmbaga, Elice Mmari, Kissa Mwamwitwa, Siphesihle Nhlabatsi, Kassech Sintayehu, Aida Arefayne, Mekonnen Teferi, Frank Cobelens, Linda Härmark
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background New medicines have become available for the treatment of drug-resistant tuberculosis (DR-TB) and are introduced in sub-Saharan Africa (SSA) by the national TB programs (NTPs) through special access schemes. Pharmacovigilance is ty
Externí odkaz:
https://doaj.org/article/75b64751ba39449e81cc8a53ff067b7d
Publikováno v:
Antibiotics, Vol 10, Iss 12, p 1512 (2021)
(1) Background: Antimicrobial resistance (AMR) requires urgent multidisciplinary solutions, and pharmacovigilance has the potential to strengthen current antimicrobial stewardship strategies. This study aimed to characterize AMR-relevant adverse drug
Externí odkaz:
https://doaj.org/article/2a41e414f2014315a2168ee39f68b3f9
Autor:
Helen R. Gosselt, Elizabeth A. Bazelmans, Thomas Lieber, Florence P. A. M. van Hunsel, Linda Härmark
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:1300-1307
The number of Individual Case Safety Reports (ICSRs) in pharmacovigilance databases are rapidly increasing world-wide. The majority of ICSRs at the Netherlands Pharmacovigilance Centre Lareb is reviewed manually to identify potential signal triggerin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deeacd4ec5a51c1baa1dcdb5a1c1c9c5
https://doi.org/10.1002/pds.5553
https://doi.org/10.1002/pds.5553
Autor:
Michael Steel, Chantal El-Haddad, Linda Härmark, Monali Desai, Ulrika Nörby, Sashka Hristoskova, Benedikte Noël-Cuppers, Ludivine Douarin
Publikováno v:
Expert Opinion on Drug Safety
Background: Inconsistencies in information on safety of medicine use during pregnancy and lactation can result in sub-optimal treatment for pregnant and lactating women, risks to the fetus or child...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38afb2b2d71595c89dfa0a0cd131fb41
https://doi.org/10.1080/14740338.2021.1935865
https://doi.org/10.1080/14740338.2021.1935865
Autor:
Monica van Hoof, Katherine Chinchilla, Linda Härmark, Cristiano Matos, Pedro Inácio, Florence van Hunsel
Publikováno v:
Drug safety. 45(10)
Involving patients in decision making adds value in the context of pharmacovigilance (PV). This added value goes beyond participation in spontaneous reporting systems for adverse drug reactions. However, there is a gap between allowing patients to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6dbb765ab04accf7ee10abbe2e2feed
https://pubmed.ncbi.nlm.nih.gov/36008634
https://pubmed.ncbi.nlm.nih.gov/36008634
Autor:
Judith Hendriks, Linda Härmark, Petra van der Horst, Anne-Marie van Gorp, Saskia Vorstenbosch, Leàn Rolfes
Publikováno v:
Pharmacoepidemiology and Drug Safety. 29:1588-1595
Purpose The primary aim of this study was to gain insight in the safety profile of the new antidiabetic agents glucagon-like peptide-1 (GLP-1) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors in daily practice. The secondary aim was to compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68231341c491f3544aaa05e8f5bf5722
https://doi.org/10.1002/pds.5077
https://doi.org/10.1002/pds.5077
Autor:
Linda Härmark, Jane Sheridan, Joanne Barnes, Christine Dong, Mira Harrison-Woolrych, Sunita Vohra
Publikováno v:
Drug Safety. 43:981-998
Intensive monitoring methods are used in pharmacovigilance for prescription medicines but have not yet been implemented for natural health products (NHPs). Our objective was to assess feasibility issues with a new ‘purchase event’ intensive monit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c714786530a8596d11fee603735f21c9
https://doi.org/10.1007/s40264-020-00963-y
https://doi.org/10.1007/s40264-020-00963-y